Skip to main content
Top
Published in: Virology Journal 1/2007

Open Access 01-12-2007 | Research

The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells

Authors: Myriam Gruener, Ignacio G Bravo, Frank Momburg, Angel Alonso, Pascal Tomakidi

Published in: Virology Journal | Issue 1/2007

Login to get access

Abstract

The human papillomavirus type 16 E5 protein (HPV16 E5) down-regulates surface expression of HLA-I molecules. The molecular mechanisms underlying this effect are so far unknown. Here we show that HPV16 E5 down-regulates HLA-I surface expression in calnexin-containing but not in calnexin-deficient cells. Immunoprecipitation experiments reveal that calnexin and HPV16E5 can be co-precipitated and that this association depends on the presence of a wild-type first hydrophobic region of E5. When an E5 mutant (M1) in which the first putative transmembrane helix had been disrupted was used for the transfections calnexin-E5 co-precipitation was strongly impaired. In addition, we show that the M1 mutant is only able to marginally down-regulate HLA-I surface expression compared to the wild-type protein. Besides, we demonstrate that E5 forms a ternary complex with calnexin and the heavy chain of HLA-I, which is mediated by the first hydrophobic region of the E5 protein. On the basis of our results we conclude that formation of this complex is responsible for retention of HLA-I molecules in the ER of the cells.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348: 518-527. 10.1056/NEJMoa021641.PubMedCrossRef Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348: 518-527. 10.1056/NEJMoa021641.PubMedCrossRef
3.
4.
go back to reference Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.PubMedCrossRef Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.PubMedCrossRef
5.
go back to reference Clifford GM, Smith JS, Aguado T, Franceschi S: Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003, 89: 101-105. 10.1038/sj.bjc.6601024.PubMedPubMedCentralCrossRef Clifford GM, Smith JS, Aguado T, Franceschi S: Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003, 89: 101-105. 10.1038/sj.bjc.6601024.PubMedPubMedCentralCrossRef
6.
go back to reference Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002, 55: 244-265.PubMedPubMedCentralCrossRef Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002, 55: 244-265.PubMedPubMedCentralCrossRef
7.
go back to reference Stoler MH, Broker TR: In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum Pathol. 1986, 17: 1250-1258.PubMedCrossRef Stoler MH, Broker TR: In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum Pathol. 1986, 17: 1250-1258.PubMedCrossRef
8.
go back to reference Crum CP, Symbula M, Ward BE: Topography of early HPV 16 transcription in high-grade genital precancers. Am J Pathol. 1989, 134: 1183-1188.PubMedPubMedCentral Crum CP, Symbula M, Ward BE: Topography of early HPV 16 transcription in high-grade genital precancers. Am J Pathol. 1989, 134: 1183-1188.PubMedPubMedCentral
9.
go back to reference Garnett TO, Duerksen-Hughes PJ: Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. Arch Virol. 2006, 151: 2321-2335. 10.1007/s00705-006-0821-0.PubMedPubMedCentralCrossRef Garnett TO, Duerksen-Hughes PJ: Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. Arch Virol. 2006, 151: 2321-2335. 10.1007/s00705-006-0821-0.PubMedPubMedCentralCrossRef
10.
go back to reference Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990, 248: 76-79. 10.1126/science.2157286.PubMedCrossRef Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990, 248: 76-79. 10.1126/science.2157286.PubMedCrossRef
11.
go back to reference Dyson N, Howley PM, Munger K, Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989, 243: 934-937. 10.1126/science.2537532.PubMedCrossRef Dyson N, Howley PM, Munger K, Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989, 243: 934-937. 10.1126/science.2537532.PubMedCrossRef
12.
go back to reference Kabsch K, Alonso A: The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J Virol. 2002, 76: 12162-12172. 10.1128/JVI.76.23.12162-12172.2002.PubMedPubMedCentralCrossRef Kabsch K, Alonso A: The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J Virol. 2002, 76: 12162-12172. 10.1128/JVI.76.23.12162-12172.2002.PubMedPubMedCentralCrossRef
13.
go back to reference Bravo IG, Crusius K, Alonso A: The E5 protein of human papillomavirus type 16 modulates composition and dynamics of membrane lipids in keratinocyte membranes. Arch Virol. 2005, 150: 231-246. 10.1007/s00705-004-0420-x.PubMedCrossRef Bravo IG, Crusius K, Alonso A: The E5 protein of human papillomavirus type 16 modulates composition and dynamics of membrane lipids in keratinocyte membranes. Arch Virol. 2005, 150: 231-246. 10.1007/s00705-004-0420-x.PubMedCrossRef
14.
go back to reference Sasagawa T, Inoue M, Tanizawa O, Yutsudo M, Hakura A: Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias. Jpn J Cancer Res. 1992, 83: 705-713.PubMedCrossRef Sasagawa T, Inoue M, Tanizawa O, Yutsudo M, Hakura A: Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias. Jpn J Cancer Res. 1992, 83: 705-713.PubMedCrossRef
15.
go back to reference Muller M, Viscidi RP, Sun Y, Guerrero E, Hill PM, Shah F, Bosch FX, Munoz N, Gissmann L, Shah KV: Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology. 1992, 187: 508-514. 10.1016/0042-6822(92)90453-V.PubMedCrossRef Muller M, Viscidi RP, Sun Y, Guerrero E, Hill PM, Shah F, Bosch FX, Munoz N, Gissmann L, Shah KV: Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology. 1992, 187: 508-514. 10.1016/0042-6822(92)90453-V.PubMedCrossRef
16.
go back to reference Dillner J: Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. Int J Cancer. 1990, 46: 703-711. 10.1002/ijc.2910460426.PubMedCrossRef Dillner J: Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. Int J Cancer. 1990, 46: 703-711. 10.1002/ijc.2910460426.PubMedCrossRef
17.
go back to reference Kochel HG, Sievert K, Monazahian M, Mittelstadt-Deterding A, Teichmann A, Thomssen R: Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products. Virology. 1991, 182: 644-654. 10.1016/0042-6822(91)90605-B.PubMedCrossRef Kochel HG, Sievert K, Monazahian M, Mittelstadt-Deterding A, Teichmann A, Thomssen R: Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products. Virology. 1991, 182: 644-654. 10.1016/0042-6822(91)90605-B.PubMedCrossRef
18.
go back to reference Auvinen E, Crusius K, Steuer B, Alonso A: Human papillomavirus type 16 E5 protein (Review). Int J Oncol. 1997, 11: 1297-1304.PubMed Auvinen E, Crusius K, Steuer B, Alonso A: Human papillomavirus type 16 E5 protein (Review). Int J Oncol. 1997, 11: 1297-1304.PubMed
19.
go back to reference O'Brien PM, Saveria Campo M: Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res. 2002, 88: 103-117. 10.1016/S0168-1702(02)00123-5.PubMedCrossRef O'Brien PM, Saveria Campo M: Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res. 2002, 88: 103-117. 10.1016/S0168-1702(02)00123-5.PubMedCrossRef
20.
go back to reference Zhang B, Li P, Wang E, Brahmi Z, Dunn KW, Blum JS, Roman A: The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Virology. 2003, 310: 100-108. 10.1016/S0042-6822(03)00103-X.PubMedCrossRef Zhang B, Li P, Wang E, Brahmi Z, Dunn KW, Blum JS, Roman A: The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Virology. 2003, 310: 100-108. 10.1016/S0042-6822(03)00103-X.PubMedCrossRef
21.
go back to reference Ashrafi GH, Haghshenas M, Marchetti B, Campo MS: E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int J Cancer. 2006, 119: 2105-2112. 10.1002/ijc.22089.PubMedCrossRef Ashrafi GH, Haghshenas M, Marchetti B, Campo MS: E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int J Cancer. 2006, 119: 2105-2112. 10.1002/ijc.22089.PubMedCrossRef
22.
go back to reference Ashrafi GH, Haghshenas MR, Marchetti B, O'Brien PM, Campo MS: E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer. 2005, 113: 276-283. 10.1002/ijc.20558.PubMedCrossRef Ashrafi GH, Haghshenas MR, Marchetti B, O'Brien PM, Campo MS: E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer. 2005, 113: 276-283. 10.1002/ijc.20558.PubMedCrossRef
23.
go back to reference Cromme FV, Snijders PJ, van den Brule AJ, Kenemans P, Meijer CJ, Walboomers JM: MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression. Oncogene. 1993, 8: 2969-2975.PubMed Cromme FV, Snijders PJ, van den Brule AJ, Kenemans P, Meijer CJ, Walboomers JM: MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression. Oncogene. 1993, 8: 2969-2975.PubMed
24.
go back to reference Marchetti B, Ashrafi GH, Tsirimonaki E, O'Brien PM, Campo MS: The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface. Oncogene. 2002, 21: 7808-7816. 10.1038/sj.onc.1205885.PubMedCrossRef Marchetti B, Ashrafi GH, Tsirimonaki E, O'Brien PM, Campo MS: The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface. Oncogene. 2002, 21: 7808-7816. 10.1038/sj.onc.1205885.PubMedCrossRef
25.
go back to reference Ortmann B, Androlewicz MJ, Cresswell P: MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature. 1994, 368: 864-867. 10.1038/368864a0.PubMedCrossRef Ortmann B, Androlewicz MJ, Cresswell P: MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature. 1994, 368: 864-867. 10.1038/368864a0.PubMedCrossRef
26.
go back to reference Ahluwalia N, Bergeron JJ, Wada I, Degen E, Williams DB: The p88 molecular chaperone is identical to the endoplasmic reticulum membrane protein, calnexin. J Biol Chem. 1992, 267: 10914-10918.PubMed Ahluwalia N, Bergeron JJ, Wada I, Degen E, Williams DB: The p88 molecular chaperone is identical to the endoplasmic reticulum membrane protein, calnexin. J Biol Chem. 1992, 267: 10914-10918.PubMed
27.
go back to reference Degen E, Cohen-Doyle MF, Williams DB: Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2-microglobulin and peptide. J Exp Med. 1992, 175: 1653-1661. 10.1084/jem.175.6.1653.PubMedCrossRef Degen E, Cohen-Doyle MF, Williams DB: Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2-microglobulin and peptide. J Exp Med. 1992, 175: 1653-1661. 10.1084/jem.175.6.1653.PubMedCrossRef
28.
go back to reference Ritz U, Momburg F, Pilch H, Huber C, Maeurer MJ, Seliger B: Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma. Int J Oncol. 2001, 19: 1211-1220.PubMed Ritz U, Momburg F, Pilch H, Huber C, Maeurer MJ, Seliger B: Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma. Int J Oncol. 2001, 19: 1211-1220.PubMed
29.
go back to reference Ayala-Torres S, Moller PC, Johnson BH, Thompson EB: Characteristics of 25-hydroxycholesterol-induced apoptosis in the human leukemic cell line CEM. Exp Cell Res. 1997, 235: 35-47. 10.1006/excr.1997.3630.PubMedCrossRef Ayala-Torres S, Moller PC, Johnson BH, Thompson EB: Characteristics of 25-hydroxycholesterol-induced apoptosis in the human leukemic cell line CEM. Exp Cell Res. 1997, 235: 35-47. 10.1006/excr.1997.3630.PubMedCrossRef
30.
go back to reference Scott JE, Dawson JR: MHC class I expression and transport in a calnexin-deficient cell line. J Immunol. 1995, 155: 143-148.PubMed Scott JE, Dawson JR: MHC class I expression and transport in a calnexin-deficient cell line. J Immunol. 1995, 155: 143-148.PubMed
31.
go back to reference Howell DN, Andreotti PE, Dawson JR, Cresswell P: Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. J Immunol. 1985, 134: 971-976.PubMed Howell DN, Andreotti PE, Dawson JR, Cresswell P: Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. J Immunol. 1985, 134: 971-976.PubMed
32.
go back to reference Bravo IG, Alonso A: Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J Virol. 2004, 78: 13613-13626. 10.1128/JVI.78.24.13613-13626.2004.PubMedPubMedCentralCrossRef Bravo IG, Alonso A: Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J Virol. 2004, 78: 13613-13626. 10.1128/JVI.78.24.13613-13626.2004.PubMedPubMedCentralCrossRef
33.
go back to reference Oetke C, Auvinen E, Pawlita M, Alonso A: Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation. Arch Virol. 2000, 145: 2183-2191. 10.1007/s007050070048.PubMedCrossRef Oetke C, Auvinen E, Pawlita M, Alonso A: Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation. Arch Virol. 2000, 145: 2183-2191. 10.1007/s007050070048.PubMedCrossRef
34.
go back to reference Gieswein CE, Sharom FJ, Wildeman AG: Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions. Virology. 2003, 313: 415-426. 10.1016/S0042-6822(03)00296-4.PubMedCrossRef Gieswein CE, Sharom FJ, Wildeman AG: Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions. Virology. 2003, 313: 415-426. 10.1016/S0042-6822(03)00296-4.PubMedCrossRef
35.
go back to reference Rodriguez MI, Finbow ME, Alonso A: Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. Oncogene. 2000, 19: 3727-3732. 10.1038/sj.onc.1203718.PubMedCrossRef Rodriguez MI, Finbow ME, Alonso A: Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. Oncogene. 2000, 19: 3727-3732. 10.1038/sj.onc.1203718.PubMedCrossRef
36.
go back to reference Yang DH, Wildeman AG, Sharom FJ: Overexpression, purification, and structural analysis of the hydrophobic E5 protein from human papillomavirus type 16. Protein Expr Purif. 2003, 30: 1-10. 10.1016/S1046-5928(03)00049-4.PubMedCrossRef Yang DH, Wildeman AG, Sharom FJ: Overexpression, purification, and structural analysis of the hydrophobic E5 protein from human papillomavirus type 16. Protein Expr Purif. 2003, 30: 1-10. 10.1016/S1046-5928(03)00049-4.PubMedCrossRef
37.
go back to reference Sonnhammer EL, von Heijne G, Krogh A: A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol. 1998, 6: 175-182.PubMed Sonnhammer EL, von Heijne G, Krogh A: A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol. 1998, 6: 175-182.PubMed
38.
go back to reference Moller S, Croning MD, Apweiler R: Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics. 2001, 17: 646-653. 10.1093/bioinformatics/17.7.646.PubMedCrossRef Moller S, Croning MD, Apweiler R: Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics. 2001, 17: 646-653. 10.1093/bioinformatics/17.7.646.PubMedCrossRef
39.
go back to reference Neefjes JJ, Momburg F, Hammerling GJ: Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science. 1993, 261: 769-771. 10.1126/science.8342042.PubMedCrossRef Neefjes JJ, Momburg F, Hammerling GJ: Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science. 1993, 261: 769-771. 10.1126/science.8342042.PubMedCrossRef
40.
go back to reference Rebai N, Malissen B: Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens. 1983, 22: 107-117.PubMedCrossRef Rebai N, Malissen B: Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens. 1983, 22: 107-117.PubMedCrossRef
41.
go back to reference Ashrafi GH, Tsirimonaki E, Marchetti B, O'Brien PM, Sibbet GJ, Andrew L, Campo MS: Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene. 2002, 21: 248-259. 10.1038/sj.onc.1205008.PubMedCrossRef Ashrafi GH, Tsirimonaki E, Marchetti B, O'Brien PM, Sibbet GJ, Andrew L, Campo MS: Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene. 2002, 21: 248-259. 10.1038/sj.onc.1205008.PubMedCrossRef
42.
go back to reference Cartin W, Alonso A: The human papillomavirus HPV2a E5 protein localizes to the Golgi apparatus and modulates signal transduction. Virology. 2003, 314: 572-579. 10.1016/S0042-6822(03)00509-9.PubMedCrossRef Cartin W, Alonso A: The human papillomavirus HPV2a E5 protein localizes to the Golgi apparatus and modulates signal transduction. Virology. 2003, 314: 572-579. 10.1016/S0042-6822(03)00509-9.PubMedCrossRef
43.
go back to reference Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RE: Continuous Culture of Human Lymphoblasts from Peripheral Blood of a Child with Acute Leukemia. Cancer. 1965, 18: 522-529. 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J.PubMedCrossRef Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RE: Continuous Culture of Human Lymphoblasts from Peripheral Blood of a Child with Acute Leukemia. Cancer. 1965, 18: 522-529. 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J.PubMedCrossRef
44.
go back to reference Loch S, Tampe R: Viral evasion of the MHC class I antigen-processing machinery. Pflugers Arch. 2005, 451: 409-417. 10.1007/s00424-005-1420-8.PubMedCrossRef Loch S, Tampe R: Viral evasion of the MHC class I antigen-processing machinery. Pflugers Arch. 2005, 451: 409-417. 10.1007/s00424-005-1420-8.PubMedCrossRef
45.
go back to reference Vossen MT, Westerhout EM, Soderberg-Naucler C, Wiertz EJ: Viral immune evasion: a masterpiece of evolution. Immunogenetics. 2002, 54: 527-542. 10.1007/s00251-002-0493-1.PubMedCrossRef Vossen MT, Westerhout EM, Soderberg-Naucler C, Wiertz EJ: Viral immune evasion: a masterpiece of evolution. Immunogenetics. 2002, 54: 527-542. 10.1007/s00251-002-0493-1.PubMedCrossRef
46.
go back to reference Zhou J, Liu WJ, Peng SW, Sun XY, Frazer I: Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J Virol. 1999, 73: 4972-4982.PubMedPubMedCentral Zhou J, Liu WJ, Peng SW, Sun XY, Frazer I: Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J Virol. 1999, 73: 4972-4982.PubMedPubMedCentral
47.
go back to reference Leder C, Kleinschmidt JA, Wiethe C, Muller M: Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol. 2001, 75: 9201-9209. 10.1128/JVI.75.19.9201-9209.2001.PubMedPubMedCentralCrossRef Leder C, Kleinschmidt JA, Wiethe C, Muller M: Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol. 2001, 75: 9201-9209. 10.1128/JVI.75.19.9201-9209.2001.PubMedPubMedCentralCrossRef
48.
go back to reference Disbrow GL, Sunitha I, Baker CC, Hanover J, Schlegel R: Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology. 2003, 311: 105-114. 10.1016/S0042-6822(03)00129-6.PubMedCrossRef Disbrow GL, Sunitha I, Baker CC, Hanover J, Schlegel R: Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology. 2003, 311: 105-114. 10.1016/S0042-6822(03)00129-6.PubMedCrossRef
49.
go back to reference Stam NJ, Spits H, Ploegh HL: Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol. 1986, 137: 2299-2306.PubMed Stam NJ, Spits H, Ploegh HL: Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol. 1986, 137: 2299-2306.PubMed
50.
go back to reference Seliger B, Ritz U, Ferrone S: Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int J Cancer. 2006, 118: 129-138. 10.1002/ijc.21312.PubMedCrossRef Seliger B, Ritz U, Ferrone S: Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int J Cancer. 2006, 118: 129-138. 10.1002/ijc.21312.PubMedCrossRef
51.
go back to reference Yewdell JW, Bennink JR: Mechanisms of viral interference with MHC class I antigen processing and presentation. Annu Rev Cell Dev Biol. 1999, 15: 579-606. 10.1146/annurev.cellbio.15.1.579.PubMedCrossRef Yewdell JW, Bennink JR: Mechanisms of viral interference with MHC class I antigen processing and presentation. Annu Rev Cell Dev Biol. 1999, 15: 579-606. 10.1146/annurev.cellbio.15.1.579.PubMedCrossRef
52.
go back to reference Vambutas A, DeVoti J, Pinn W, Steinberg BM, Bonagura VR: Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport. Clin Immunol. 2001, 101: 94-99. 10.1006/clim.2001.5094.PubMedCrossRef Vambutas A, DeVoti J, Pinn W, Steinberg BM, Bonagura VR: Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport. Clin Immunol. 2001, 101: 94-99. 10.1006/clim.2001.5094.PubMedCrossRef
53.
go back to reference Alonso A, Reed J: Modelling of the human papillomavirus type 16 E5 protein. Biochim Biophys Acta. 2002, 1601: 9-18.PubMedCrossRef Alonso A, Reed J: Modelling of the human papillomavirus type 16 E5 protein. Biochim Biophys Acta. 2002, 1601: 9-18.PubMedCrossRef
54.
go back to reference Bravo I, Alonso A, Auvinen E: Human papillomavirus type 16 E5 protein. Papillomavirus Report. 2004, 15: 1-6. 10.1179/095741904225004233.CrossRef Bravo I, Alonso A, Auvinen E: Human papillomavirus type 16 E5 protein. Papillomavirus Report. 2004, 15: 1-6. 10.1179/095741904225004233.CrossRef
55.
go back to reference Cid-Arregui A, Juarez V, zur Hausen H: A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J Virol. 2003, 77: 4928-4937. 10.1128/JVI.77.8.4928-4937.2003.PubMedPubMedCentralCrossRef Cid-Arregui A, Juarez V, zur Hausen H: A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J Virol. 2003, 77: 4928-4937. 10.1128/JVI.77.8.4928-4937.2003.PubMedPubMedCentralCrossRef
56.
go back to reference Samorski R, Gissmann L, Osen W: Codon optimized expression of HPV 16 E6 renders target cells susceptible to E6-specific CTL recognition. Immunol Lett. 2006, 107: 41-49. 10.1016/j.imlet.2006.07.003.PubMedCrossRef Samorski R, Gissmann L, Osen W: Codon optimized expression of HPV 16 E6 renders target cells susceptible to E6-specific CTL recognition. Immunol Lett. 2006, 107: 41-49. 10.1016/j.imlet.2006.07.003.PubMedCrossRef
Metadata
Title
The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells
Authors
Myriam Gruener
Ignacio G Bravo
Frank Momburg
Angel Alonso
Pascal Tomakidi
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2007
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-4-116

Other articles of this Issue 1/2007

Virology Journal 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine